Abstract
Mathematical modelling allows one to study complex processes that may not be completely amenable to direct observation. The modelling approach requires the researcher to make explicit assumptions about the phenomenon he is studying and to place these within a rigorous mathematical framework. In this paper, we will describe some of the work that has been done in the specific area of drug resistance, beginning with earlier minimal models of the phenomenon, and then going on to discuss refinements that have been incorporated into the basic model structure.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hill, B.T. (1982). Biochemical and Cell Kinetic Aspects of Drug Resistance. In Drug and Hormone Resistance in Neoplasia; eds. Bruchovsky, N. and Goldie, J.H., vol. 1, pp. 21–53. CRC press, Boca Raton, Florida.
Goldie, J.H. and Coldman, A.J. (1979). The genetic origin of drug resistance in neoplasms: Implication for systemic therapy. Cancer Res. 44:3643–3653.
Goldie, J.H. and Coldman, A.J. (1979). A Mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat. Rep. 63:1727–1733.
Luria, S.E. and Delbruck, M. (1943). Mutation of bacteria from virus sensitivity to virus resistance. Genetics 28:491–511.
Law, L.W. (1952). Origin of the resistance of leukemic cells to folic acid antagonists. Nature (London) 169:628–629.
De Vita, V.T., Jr. (1983). The relationship between tumor mass and resistance to chemotherapy. Caner 51:1209–1220.
Skipper, H.E. (1980). ‘Some Thoughts Regarding a Recent Publication by Goldie and Coldman Entitled “A Mathematic Model for Relating the Drug Resistance of Tumors to Their Spontaneous Mutation Rate”’ In Booklet 9, Southern Research Institute, Birmingham, Ala.
Buzdar, A.U., Smith, T.L., Blumenschein, G.R., et al. (1984). Breast cancer adjuvant therapy trials of MD Anderson Hospital: Results of two studies. In Adjuvant Therapy of Cancer IV; eds. Jones, S.E. and Salmon, S.E., Grune and Stratton, New York, pp. 227–234.
Bonadonna, G., Rossi, A., Tancini, G., et al. (1984). Adjuvant chemotherapy trials in resectable breast cancer with positive axillary nodes. In The Experience of the Milan Cancer Institute in Adjuvant Therapy of Cancer IV, eds. Jones, S.E. and Salmon, S.E., Grune and Stratton, New York, pp. 193–208.
Goldie, J.H. (1983). Relevance of Drug Resistance in Cancer Treatment Strategy. In Cancer Chemotherapy I, ed. Muggia, F.M., Martinus Nejhoff, pp. 1–30.
Schackney, S., McCormack, G.W., Cuckurol, G.J., Jr. (1978). Growth rate pattern of solid tumors and their relation to responsiveness to therapy: An analytic review. Ann. Intern. Med. 89:107–121.
Goldie, J.H. and Coldman, A.J. (1983). Quantitative model for multiple levels of drug resistance in clinical tumors. Cancer Treat. Rep. 67:923–931.
Buick, R.N. and MacKillop, W.J. (1981). Measurement of self-renewal in culture of clonogenic cells from human ovarian carcinoma. Br. J. Cancer 44:349–355.
Bush, R.S., DeBoer, G. and Hill, R.P. (1982), Long Term Survival with Gynecological Cancer. In Prolonged Arrest of Cancer; ed. Stoll, B.A., John Wiley and Sons, New York, pp. 27–58.
Goldie, J.H. and Coldman, A.J. A model for tumor response to chemotherapy: An integration of the stem cell and somatic mutation hypotheses. Cancer Invest. 3(6):553–564.
Coldman, A.J., Goldie, J.H. and Ng, V. (1983). The effect of Cellular differentiation on the development of permanent drug resistance. Math. Biosciences 74:177–198.
Skipper, H.E., Schabel, F.M., Jr. and Wilcox, W.S. (1964). Experimental evaluation of potential anticancer agents XII on the criteria and kinetics associated with Curability of experimental leukemia. Cancer Chemother, Rep. 35:1–111.
Goldie, J.H., Coldman, A.J. and Gudauskas, G.A. (1982). Rationale for the use of alternating non-cros resistant chemotherapy. Cancer Treat. Rep. 66:439–449.
Goldie, J.H. and Coldman, A.J. (1986). Application of theoretical models to chemotherapy protocol design, cancer Treat. Rep. 70:127–131.
Evans, W.K., Feld, R., Murray, N., et al. (1987). Superiority of alternating non-cross resistant chemotherapy in extensive small cell lung cancer. Ann. Int. Med. 107:451–458.
Day, R. (1986). Treatment Sequencing Uncertainty and Asymmetry: Protocol strategies For Combination Chemotherapy. Cancer Res. 46:3876–3885.
Bonadonna, G., Virani, S. and Bonfante, V. (1984). Alternating chemotherapy with MOPP/ABVD in Hodgkin’s disese. Updated results. Proc. Am. Soc. Clin. Oncol. 3:254.
Klimo, P. and Connors, J.M. (1985). MOPP/ABV hybrid program: Combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin’s disease. J. Clin. Oncol. 3:1174–1182.
DeVita, V.T., Jr., Hubbard, S.M. and Longo, D.L. (1987). The chemotherapy of lymphoma: Looking back, moving forward. Cancer Res. 47:5810–5824.
Hyrniuk, W.M. and Bush, H. (1984). The importance of dose intensity in the chemotherapy of metastatic breast cancer. J. Clin. Oncol. 2:1281–1288.
Levin, L. and Hryniuk, W.M. (1977). Dose intensity analysis of chemotherapy regimens in ovarian cancer. J. Clin. Oncol. 5:756–769.
Coldman, A.J. and Goldie, J.H. (1988). Impact of dose-intense chemotherapy on the development of permanent drug resistance. Seminars in Oncology, in press.
Coldman, A.J., Coppin, C.M.L. and Goldie, J.H. (1988). Models of dose intensity, submitted.
Goldie, J.H. and Coldman, A.J. (1983). Clinical implications of the phenomenon of drug resistance. In Drug and Hormone Resistance in Neoplasia, eds. Bruchovsky, N. and Goldie, J.H., Boca Raton, vol. II, pp. 111–127.
Goldie, J.H., Coldman, A.J., Ng, V., Hopkins, H.A. and Looney, W.B. (1988). A Mathematical and computer based model of alternating chemotherapy and radiation therapy in experimental neoplasms. Lung Cancer Res., in press.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Goldie, J.H. (1989). Mathematical models of drug resistance and chemotherapy effects. In: Ozols, R.F. (eds) Drug Resistance in Cancer Therapy. Cancer Treatment and Research, vol 48. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1601-5_2
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1601-5_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8886-2
Online ISBN: 978-1-4613-1601-5
eBook Packages: Springer Book Archive